West Pharmaceutical Servi... (WST)
undefined
undefined%
At close: undefined
330.05
0.01%
After-hours Dec 13, 2024, 04:56 PM EST

West Pharmaceutical Services Statistics

Share Statistics

West Pharmaceutical Services has 72.42M shares outstanding. The number of shares has increased by -1.96% in one year.

Shares Outstanding 72.42M
Shares Change (YoY) n/a
Shares Change (QoQ) -0.41%
Owned by Institutions (%) n/a
Shares Floating 71.99M
Failed to Deliver (FTD) Shares 3
FTD / Avg. Volume 0%

Short Selling Information

The latest short interest is 1.43M, so 1.98% of the outstanding shares have been sold short.

Short Interest 1.43M
Short % of Shares Out 1.98%
Short % of Float 1.99%
Short Ratio (days to cover) 1.83

Valuation Ratios

The PE ratio is 44.09 and the forward PE ratio is 44.83. West Pharmaceutical Services 's PEG ratio is 6.91.

PE Ratio 44.09
Forward PE 44.83
PS Ratio 8.87
Forward PS 7.8
PB Ratio 9.08
P/FCF Ratio 63.12
PEG Ratio 6.91
Financial Ratio History

Enterprise Valuation

West Pharmaceutical Services Inc. has an Enterprise Value (EV) of 25.62B.

EV / Earnings 43.17
EV / Sales 8.68
EV / EBITDA 30.35
EV / EBIT 37.9
EV / FCF 61.8

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.08.

Current Ratio 2.88
Quick Ratio 2.24
Debt / Equity 0.08
Total Debt / Capitalization 7.23
Cash Flow / Debt 3.46
Interest Coverage 75.11

Financial Efficiency

Return on equity (ROE) is 0.21% and return on capital (ROIC) is 17.48%.

Return on Equity (ROE) 0.21%
Return on Assets (ROA) 0.15%
Return on Capital (ROIC) 17.48%
Revenue Per Employee 278.28K
Profits Per Employee 55.98K
Employee Count 10.60K
Asset Turnover 0.77
Inventory Turnover 4.19

Taxes

Income Tax 122.30M
Effective Tax Rate 0.18

Stock Price Statistics

The stock price has increased by -7.87% in the last 52 weeks. The beta is 1, so West Pharmaceutical Services 's price volatility has been higher than the market average.

Beta 1
52-Week Price Change -7.87%
50-Day Moving Average 311.55
200-Day Moving Average 329.97
Relative Strength Index (RSI) 59.79
Average Volume (20 Days) 603.82K

Income Statement

In the last 12 months, West Pharmaceutical Services had revenue of $2.95B and earned $593.40M in profits. Earnings per share was $7.99.

Revenue 2.95B
Gross Profit 1.13B
Operating Income 676.00M
Net Income 593.40M
EBITDA 844.10M
EBIT 676.00M
Earnings Per Share (EPS) 7.99
Full Income Statement

Balance Sheet

The company has $853.90M in cash and $309.00M in debt, giving a net cash position of $544.90M.

Cash & Cash Equivalents 853.90M
Total Debt 309.00M
Net Cash 544.90M
Retained Earnings 3.52B
Total Assets 3.68B
Working Capital 1.03B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $776.50M and capital expenditures -$362.00M, giving a free cash flow of $414.50M.

Operating Cash Flow 776.50M
Capital Expenditures -362.00M
Free Cash Flow 414.50M
FCF Per Share 5.58
Full Cash Flow Statement

Margins

Gross margin is 38.28%, with operating and profit margins of 22.92% and 20.12%.

Gross Margin 38.28%
Operating Margin 22.92%
Pretax Margin 23.66%
Profit Margin 20.12%
EBITDA Margin 28.62%
EBIT Margin 22.92%
FCF Margin 14.05%

Dividends & Yields

WST pays an annual dividend of $0.84, which amounts to a dividend yield of 0.25%.

Dividend Per Share $0.84
Dividend Yield 0.25%
Dividend Growth (YoY) 5%
Payout Ratio 12.44%
Earnings Yield 2.42%
FCF Yield 1.73%
Dividend Details

Analyst Forecast

The average price target for WST is $430, which is 30.3% higher than the current price. The consensus rating is "Strong Buy".

Price Target $430
Price Target Difference 30.3%
Analyst Consensus Strong Buy
Analyst Count 5
Stock Forecasts

Stock Splits

The last stock split was on Sep 27, 2013. It was a forward split with a ratio of 2:1.

Last Split Date Sep 27, 2013
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 18.1
Piotroski F-Score 5